3 IPOs that could expose your wealth to danger

Early investors in McGrath Ltd (ASX:MEA), Temple & Webster Group Ltd (ASX:TPW) and Wellard Ltd (ASX:WLD) have endured significant share price falls.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In the space of just four months, three newly-listed companies which all undertook initial public offerings (IPOs) have experienced dramatic share price falls.

High profile Sydney-based real estate agency McGrath Ltd (ASX: MEA) shares have fallen around 25% since first trading on the ASX in early December.

Meanwhile, shareholders who acquired stock in online furniture and homewares retailer Temple & Webster Group Ltd (ASX: TPW) on the opening day of trade are nursing losses approaching 70%!

Rounding out this group of recent listings is agribusiness Wellard Ltd (ASX: WLD). Its share price has tumbled close to 50%.

What can investors learn from these IPOs?

These dramatic share price declines are a reminder that investing in an IPO does not guarantee a profit.

In fact, IPOs in many ways carry more risks than investing in already listed companies.

There are multiple reasons for this heightened risk including the market timing of sellers, the motivation for a deal by investment bankers, and a lack of operational information being provided to potential acquirers.

The float of McGrath is arguably a typical scenario where the timing of the float would appear to have coincided with the top of the property market cycle.

Meanwhile, the floats of both Temple & Webster and Wellard would appear to have carried the risk of less informed buyers purchasing shares from well-informed sellers.

Of course it's not just individual investors with less access to management and private briefings who have come off poorly from these three floats. Plenty of professional fund managers with teams of analysts behind them also backed these IPOs and are nursing significant losses too.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »